The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear₩2,625.84Fair value₩6,525.94Bull₩8,708.16
FairClose
52-week traded range
52W low ₩2,430.0052W high ₩2,930.00
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading below the consensus fair value
BioSmart Co., Ltd. closed at ₩2,650.00, 59.4% below the consensus fair value of ₩6,525.94 drawn from 9 valuation models.
Financial DNA score 51/100 — Good. P/E of 7.4x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
₩6,672.34
+151.8%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
Graham Number
₩6,720.32
+153.6%
√(22.5 × EPS × BVPS)
EPS=356, BVPS=5638.3
Graham Formula
₩4,034.67
+52.3%
EPS × (8.5 + 2g) × 4.4 ÷ FD_Rate
g=0%, FD=3.3%
P/E Fair Value
₩7,120.00
+168.7%
EPS × 20x (sector P/E)
EPS=356, Sector P/E=20x
Peter Lynch (PEG)
₩4,414.40
+66.6%
EPS × Growth% (PEG = 1 is fair)
EPS=356, g=12.4%
EV/EBITDA
₩8,708.16
+228.6%
(EBITDA × 10x − Net Debt) ÷ Shares
EBITDA=29.16B
Book Value (P/B)
₩2,625.84
-0.9%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=5638.3, ROE=6.3%, g=3%, r=10%
Reverse DCF
₩2,650.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: -6.5% | Historical: -12.4%
Margin of Safety
₩4,602.62
+73.7%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=6136.83, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.